Susan G. Komen's ShareForCures

Breast Cancer Clinical Trial

Official title:

ShareForCures: Susan G. Komen's People-powered, Data-driven Breast Cancer Research Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05654246
• Other study ID #: SGK-SFC-001
• Status: Recruiting
• Start date: November 17, 2022
• Est. completion date: November 2032

Study information

• Verified date: March 2024
• Source: Susan G. Komen Breast Cancer Foundation
• Contact: Jerome Jourquin, Ph.D., M.S.
• Phone: 1-877-465-6636
• Email: JJourquin[@]komen.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.

Description:

ShareForCures (SFC) will be a people-powered, data-driven breast cancer registry that will provide a way for individuals from diverse backgrounds to participate in research and enable participants' data to be used for breast cancer research. The overarching goal of SFC is to create a robust research resource comprised of clinical, biological, socio-behavioral, and other data from up to 200,000 people with breast cancer-including minoritized and historically marginalized people, persons, or communities-to ensure the data, researchers use to study breast cancer, is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer and everyone can potentially benefit from scientific advances and improvements in care.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200000
• Est. completion date: November 2032
• Est. primary completion date: November 2032
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate).
• Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.
• Individuals must be currently residing in the United States or a territory of the United States.
• Individuals must be able to read and understand English.

Exclusion Criteria:

• Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate).
• Individuals without a diagnosis of breast cancer.
• Individuals who are not residing in the United States or a territory of the United States.
• Individuals unable to read and understand English.

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Locations

Country	Name	City	State
United States	Susan G. Komen	Dallas	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Susan G. Komen Breast Cancer Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Engage participants representative of the United States breast cancer patient population in ShareForCures.	Enroll and engage up to 200,000 people, who have been diagnosed with breast cancer, reflecting the diversity of breast cancer survivors within the United States, to participate in the registry as our partners in research.	10 years
Primary	Integrate participant data into ShareForCures.	Collect and curate a rich scope of participant data from a variety of sources (including participant-provided information, clinical records, and linkage to other existing datasets) and biospecimens to create a comprehensive, longitudinal database.	10 years
Primary	Facilitate scientific research using ShareForCures data.	Make deidentified data available to researchers for scientific discoveries, including research that may lead to new knowledge about breast cancer and advances in patient care and outcomes.	10 years